(Q34979057)

5 August 2017

Intrauterine growth restriction: screening, diagnosis, and management (English)

1 reference

intrauterine growth restriction

5 August 2017

0 references

1 reference

Andrea Lausman

1

1 reference

PubMed ID

24007710

5 August 2017

John Kingdom

series ordinal

2

1 reference

PubMed ID

24007710

5 August 2017

MATERNAL FETAL MEDICINE COMMITTEE

series ordinal

3

1 reference

5 August 2017

1 August 2013

1 reference

Journal of Obstetrics and Gynaecology Canada

5 August 2017

1 reference

5 August 2017

35

1 reference

5 August 2017

8

1 reference

5 August 2017

741-748

1 reference

TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Prenatal diagnosis of fetal growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Predictors of Neonatal Outcome in Early- Onset Placental Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT)

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

A standard of fetal growth for the United States of America

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Routine doppler ultrasound in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Routine ultrasound in late pregnancy (after 24 weeks' gestation)

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants in low-risk pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Screening for fetal growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Fetal death after normal biophysical profile score: An eighteen-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

A systematic review of the ultrasound estimation of fetal weight

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Quad screen as a predictor of adverse pregnancy outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Customised assessment of fetal growth potential: implications for perinatal care

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Customised antenatal growth charts

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Antenatal cardiotocography for fetal assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Regimens of fetal surveillance for impaired fetal growth

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Screening, diagnosis, and management of intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

The implications of introducing the symphyseal-fundal height-measurement. A prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of growth-restricted fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Fetal growth compromise: definitions, standards, and classification

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Clinical features of fetal growth restriction complicated later by preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Ultrasound assessment of abnormal fetal growth

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Placenta and umbilical cord abnormalities seen with stillbirth

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Pathologic basis of echogenic cystic lesions in the human placenta: role of ultrasound-guided wire localization

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Effects of maternal tobacco-smoke exposure on fetal growth and neonatal size

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Symphysial fundal height (SFH) measurement in pregnancy for detecting abnormal fetal growth

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Understanding the link between the placenta and future cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Maternal uterine artery Doppler flow velocimetry and the risk of stillbirth.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Fetal growth retardation: associated malformations and chromosomal abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Isolated oligohydramnios is not associated with adverse perinatal outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2815%2930865-3

7 January 2021

Doppler ultrasound for fetal assessment in high risk pregnancies.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000073

Identifiers

DOI

10.1016/S1701-2163(15)30865-3

1 reference

5 August 2017

1 reference

PubMed ID

24007710